MDXG Prakiraan wutah bathi kanggo taun ngarep mimedx.com
The diversification of placental biologics for surgery and orthopedics reduces risks for MiMedx Group, Inc. (MDXG), confirming the trajectory of forward expectations for net income. The value of 114.30 indicates the current level of this metric. MiMedx Group, Inc. (MDXG) is developing partnerships with hospitals to implement regenerative therapy. Standard environmental controls and production sterility complement the business's operating model.
MDXG (MiMedx Group Inc): rincian analitis lan laporan miturut indikator
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal MiMedx Group, Inc.|MDXG - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas MiMedx Corp|MDXG - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku MiMedx Group|MDXG - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan MiMedx|Rasio cepet mimedx.com
- data bathi resik lan rasio valuasi:
MDXG - Asil keuangan resik|Bathi sing dikarepake MiMedx Group, Inc.|MDXG - Koefisien rega marang bathi|Pangali Forward P/E MiMedx Corp|MDXG - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA MiMedx Corp|MDXG - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan MiMedx|MDXG - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan mimedx.com|MDXG - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep MiMedx Group, Inc.
- data total pendapatan lan volume dodolan:
Analisis wiwitan perusahaan:MDXG, mimedx.com
Portfolio managers evaluate the operating model of MiMedx Group, Inc. (MDXG) through a consensus earnings forecast, which measures market confidence in the business's ability to scale net income over the short term. By analyzing the projected earnings growth for the coming year, investors can determine how effectively the ambitious strategy for implementing placental biomaterials and the engagement of a highly skilled surgical staff convert into the asset's future financial stability.
Analisis perusahaan pesaing
ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Corp|89bio Pharma (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep agios.com (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep structuretx.com GPCR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MBX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Altimmune Corp - Proyeksi tambahing bathi saben saham ing taun ngarep|Aardvark Therapeutics Inc (AARD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Biomea Fusion (BMEA)|Prakiraan wutah bathi kanggo taun ngarep QNCX|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep
